title: A mathematical model of the circadian phase-shifting effects of exogenous melatonin.
abstract: Melatonin is endogenously produced and released in humans during nighttime darkness and is suppressed by ocular light exposure. Exogenous melatonin is used to induce circadian phase shifts and sleep. The circadian phase-shifting ability of a stimulus (e.g., melatonin or light) relative to its timing may be displayed as a phase response curve (PRC). Published PRCs to exogenous melatonin show a transition from phase advances to delays approximately 1 h after dim light melatonin onset. A previously developed mathematical model simulates endogenous production and clearance of melatonin as a function of circadian phase, light-induced suppression, and resetting of circadian phase by light. We extend this model to include the pharmacokinetics of oral exogenous melatonin and phase-shifting effects via melatonin receptors in the suprachiasmatic nucleus of the mammalian hypothalamus. Model parameters are fit using 2 data sets: (1) blood melatonin concentration following a 0.3- or 5.0-mg dose, and (2) a PRC to a 3.0-mg dose of melatonin. After fitting to the 3.0-mg PRC, the model correctly predicts that, by comparison, the 0.5-mg PRC is slightly decreased in amplitude and shifted to a later circadian phase. This model also reproduces blood concentration profiles of various melatonin preparations that differ only in absorption rate and percentage degradation by first-pass hepatic metabolism. This model can simulate experimental protocols using oral melatonin, with potential application to guide dose size and timing to optimally shift and entrain circadian rhythms.
authors: Division of Sleep Medicine, Brigham & Women's Hospital, Harvard Medical School, MA 02115, USA.
authors: Emily R
authors: ER
authors: Breslow
authors: Andrew J K
authors: AJ
authors: Phillips
authors: Jean M
authors: JM
authors: Huang
authors: Melissa A
authors: MA
authors: St Hilaire
authors: Elizabeth B
authors: EB
authors: Klerman
mesh_terms: D001831:Body Temperature / Q000187:drug effects / Q000502:physiology; D002940:Circadian Rhythm / Q000187:drug effects* / Q000502:physiology*; D003624:Darkness; D006801:Humans; D008027:Light; D008550:Melatonin / Q000493:pharmacokinetics / Q000494:pharmacology*; D008954:Models, Biological; D044094:Receptors, Melatonin / Q000378:metabolism; D012890:Sleep / Q000187:drug effects* / Q000502:physiology*; D013493:Suprachiasmatic Nucleus / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D014785:Vision, Ocular / Q000187:drug effects / Q000502:physiology
chemical_list: D044094:Receptors, Melatonin; D008550:Melatonin
references: J Physiol. 2000 Aug 1;526 Pt 3:695-702
references: 10922269
references: J Pineal Res. 2000 Nov;29(4):193-200
references: 11068941
references: J Theor Biol. 2011 Mar 21;273(1):44-54
references: 21176782
references: Neuroendocrinology. 1994 Jul;60(1):105-12
references: 8090277
references: Sleep. 2000 Aug 1;23(5):663-9
references: 10947034
references: Sleep Med Rev. 2005 Feb;9(1):11-24
references: 15649735
references: Brain Res. 1995 Aug 7;688(1-2):77-85
references: 8542325
references: Surgery. 1962 Feb;51(2):224-32
references: 21936146
references: Sleep. 2006 May;29(5):609-18
references: 16774150
references: J Clin Endocrinol Metab. 2010 Jul;95(7):3325-31
references: 20410229
references: J Biol Rhythms. 2011 Oct;26(5):441-53
references: 21921298
references: J Pineal Res. 2007 Oct;43(3):294-304
references: 17803528
references: Sleep. 2004 Nov 1;27(7):1319-25
references: 15586784
references: Cochrane Database Syst Rev. 2002;(2):CD001520
references: 12076414
references: Curr Med Chem. 2010;17(19):2070-95
references: 20423309
references: Sleep Med Rev. 2005 Feb;9(1):51-65
references: 15649738
references: J Biol Rhythms. 1999 Dec;14(6):500-15
references: 10643747
references: J Physiol. 2003 Jun 15;549(Pt 3):945-52
references: 12717008
references: J Theor Biol. 2007 Aug 21;247(4):583-99
references: 17531270
references: Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1824-8
references: 8127888
references: Clin Pharmacol Ther. 1995 May;57(5):552-8
references: 7768078
references: J Endocrinol. 2000 Jan;164(1):R1-6
references: 10607943
references: Adv Psychobiol. 1976;3:35-74
references: 970276
references: J Biol Rhythms. 2007 Apr;22(2):167-79
references: 17440218
references: J Reprod Fertil. 1992 Aug;95(3):935-46
references: 1357168
references: J Biol Rhythms. 2002 Apr;17(2):181-93
references: 12002165
references: J Physiol. 2008 Jan 15;586(2):639-47
references: 18006583
references: Br J Clin Pharmacol. 1985 Apr;19(4):517-21
references: 3994899
references: Am J Physiol. 1997 Mar;272(3 Pt 1):E506-16
references: 9124558
references: Chem Res Toxicol. 1998 Mar;11(3):234-40
references: 9544622
references: Chronobiol Int. 1992 Oct;9(5):380-92
references: 1394610
references: Chronobiol Int. 1998 Jan;15(1):71-83
references: 9493716
references: Neuroendocrinology. 1984 Oct;39(4):307-13
references: 6493445
references: J Biol Rhythms. 1999 Dec;14(6):532-7
references: 10643750
references: Science. 1988 Oct 7;242(4875):78-81
references: 2845576